Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06196489 · ClinicalTrials.gov registry record · NA
Adapting an Intervention for Vaping in Young Veterans
A NA study of E-cigarette Use, sponsored by Veterans Medical Research Foundation.
- Recruiting
- Registry status
- NA
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT06196489: Recruiting NA study of E-cigarette Use, sponsored by Veterans Medical Research Foundation.
NCT06196489 is a NA study of E-cigarette Use that is actively recruiting participants, run by Veterans Medical Research Foundation. The registered enrollment target is 20 participants, below the 203-participant average among 12 other E-cigarette Use trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06196489, a NA study of E-cigarette Use, is actively recruiting participants, sponsored by Veterans Medical Research Foundation.
- RECRUITING
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of this proposal is to adapt an evidence-based combustible tobacco counseling intervention following an evidence-based process to include e-cigarette use and update its components for emerging adults (EA). 1. Examine factors related to e-cigarette use, barriers to cessation, and facilitators of use of cessation services among an EA population. 2. Beta-test an initial version of the intervention, delivered via video telehealth and telephone, to examine usability and acceptability.
Primary Outcome
number of days using e-cigarettes in the past 7 days at the time of assessment
Conditions Studied
Interventions
- BEHAVIORAL adapted vaping cessation intervention
Study Locations (1)
California
- Veterans Medical Research Foundation - San Diego
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2024-01-01 |
| Est. Completion | 2026-06 |
| Phase | NA |
What NCT06196489 shows while recruiting
NCT06196489 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 203-participant average among 12 other E-cigarette Use trials with a reported enrollment target (90% lower).
The record links to 1 condition, with E-cigarette Use appearing as the primary indexed condition, and to 1 intervention - of which adapted vaping cessation intervention is the first listed.
NCT06196489 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT06196489 about?
NCT06196489 is a clinical study titled "Adapting an Intervention for Vaping in Young Veterans". The objective of this proposal is to adapt an evidence-based combustible tobacco counseling intervention following an evidence-based process to include e-cigarette use and update its components for emerging adults (EA). 1. Examine factors related to e-cigarette use, barriers to cessation, and facil...
What is the current status of trial NCT06196489?
This trial is currently recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2024-01-01. Estimated completion is 2026-06.
What conditions does trial NCT06196489 study?
This clinical trial studies the following conditions: E-cigarette Use.
What interventions are being tested in trial NCT06196489?
The interventions under investigation include: adapted vaping cessation intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT06196489?
This trial is sponsored by Veterans Medical Research Foundation, which has 35 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06196489 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for E-cigarette Use
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06196489's enrollment target sits among peer trials
20 13th of 12 the lowest of 12 other E-cigarette Use trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other E-cigarette Use trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Vape-Free Text-Messaging: Pilot Study
RECRUITING · NA
-
Effects of a Low Nicotine Standard and Tobacco Prices on Illegal Cigarette Purchasing
RECRUITING · NA
-
Noncombustible Nicotine Delivery Systems as Potential Harm Reduction Tools for Persistent Cigarette Smokers
RECRUITING · NA
-
An Online Intervention to Reduce E-cigarette Use and Susceptibility to Smoking in Young Adults
RECRUITING · NA
-
Tobacco Product Susceptibility and Substitutability by Rurality and Alcohol Use
COMPLETED · NA
-
PACE Vape Messaging Study
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI